ArticleOncology2023

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.

Hideko Ohama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.